The Kidney Transplant Morbidity Index (KTMI) is a novel prognostic morbidity index to help determine the impact that pretransplant comorbid conditions have on transplant outcome.
Objective
To use national data to validate the KTMI.
Design
Retrospective analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database.
Setting and Participants
The study sample consisted of 100 261 adult patients who received a kidney transplant between 2000 and 2008.
Main Outcome Measure
Kaplan-Meier survival curves were used to demonstrate 3-year graft and patient survival for each KTMI score. Cox proportional hazards regression models were created to determine hazards for 3-year graft failure and patient mortality for each KTMI score.
Results
A sequential decrease in graft survival (0 = 91.2%, 1 = 88.2%, 2 = 85.4%, 3 = 81.7%, 4 = 77.8%, 5 = 74.0%, 6 = 69.8%, and ≥7 = 68.7) and patient survival (0 = 98.2%, 1 = 96.6%, 2 = 93.7%, 3 = 89.7%, 4 = 84.8%, 5 = 80.8%, 6 = 76.0%, and ≥7 = 74.7%) is seen as KTMI scores increase. The differences in graft and patient survival between KTMI scores are all significant (P < .001) except between 6 and ≥7. Multivariate regression analysis reveals that KTMI is an independent predictor of higher graft failure and patient mortality rates and that risk increases as KTMI scores increase.
Conclusion
The KTMI strongly predicts graft and patient survival by using pretransplant comorbid conditions; therefore, this easy-to-use tool can aid in determining outcome risk and transplant candidacy before listing, particularly in candidates with multiple comorbid conditions.
Get full access to this article
View all access options for this article.
References
1.
LezzoniLE. Risk Adjustment for Measuring Health Care Outcomes.Chicago, IL: Health Administration Press; 2003.
2.
KauffmanHMMcBrideMACorsCSRozaAMWynnJJ. Early mortality rates in older kidney recipients with comorbid risk factorsTransplantation.2007;83(4):404–410.
3.
VerouxMGrossoGCoronaD. Age is an important predictor of kidney transplantation outcomeNephrol Dial Transplant.2012;27(4):1663–1671.
4.
Meier-KriescheHOjoAOArndorferJA. Recipient age as an independent risk factor for chronic renal allograft failureTransplant Proc.2001;33(1–2):1113–1114.
5.
Meier-KriescheHUOjoAOCibrikDM. Relationship of recipient age and development of chronic allograft failureTransplantation.2000;70(2):306–310.
6.
DempsterNJCeresaCDAitkenEKingsmoreD. Outcomes following renal transplantation in older people: A retrospective cohort studyBMC Geriatr.2013;13:79.
CosioFGHicksonLJGriffinMDStegallMDKudvaY. Patient survival and cardiovascular risk after kidney transplantation: The challenge of diabetesAm J Transplant.2008;8(3):593–599.
9.
DíazJMGichIBonfillX. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survivalTransplant Proc.2009;41(6):2151–2155.
10.
FazelzadehAMehdizadehAOstovanMARaiss-JalaliGA. Incidence of cardiovascular risk factors and complications before and after kidney transplantationTransplant Proc.2006;38(2):506–508.
11.
HumarAKerrSRRamcharanTGillinghamKJMatasAJ. Peri-operative cardiac morbidity in kidney transplant recipients: Incidence and risk factorsClin Transplant.2001;15(3):154–158.
12.
JelokaTKRossHSmithR. Renal transplant outcome in high-cardiovascular risk recipientsClin Transplant.2007;21(5):609–614.
13.
Centers for Medicare & Medicaid Services (CMS), HHS. Medicare program; hospital conditions of participation: Requirements for approval and re-approval of transplant centers to perform organ transplants. Final rule. Fed Regist.2007;72(61):15197–15280.
14.
JassalSVSchaubelDEFentonSS. Baseline comorbidity in kidney transplant recipients: A comparison of comorbidity indicesAm J Kidney Dis.2005;46(1):136–142.
15.
MooreJHeXLiuX. Mortality prediction after kidney transplantation: Comparative clinical use of 7 comorbidity indicesExp Clin Transplant.2011;9(1):32–41.
16.
KasiskeBLIsraniAKSnyderJJSkeansMAPengYWeinhandlED. A simple tool to predict outcomes after kidney transplantAm J Kidney Dis.2010;56(5):947–960.
17.
HernándezDRufinoMBartolomeiSLorenzoVGonzález-RinneATorresA. A novel prognostic index for mortality in renal transplant recipients after hospitalizationTransplantation.2005;79(3):337–343.
18.
HernándezDSánchez-FructuosoAGonzález-PosadaJM; Spanish Late Allograft Dysfunction Study Group. A novel risk score for mortality in renal transplant recipients beyond the first posttransplant year. Transplantation.2009;88(6):803–809.
19.
BrennanTVBostromAFengS. Optimizing living donor kidney graft function by donor-recipient pair selectionTransplantation.2006;82(5):651–656.
20.
AklAIsmailAMGhoneimM. Prediction of graft survival of living-donor kidney transplantation: Nomograms or artificial neural networks?Transplantation.2008;86(10):1401–1406.
21.
RaoPSSchaubelDEGuidingerMK. A comprehensive risk quantification score for deceased donor kidneys: The kidney donor risk indexTransplantation.2009;88(2):231–236.
22.
TiongHYGoldfarbDAKattanMW. Nomograms for predicting graft function and survival in living donor kidney transplantation based on the UNOS RegistryJ Urol.2009;181(3):1248–1255.
23.
van WalravenCAustinPCKnollG. Predicting potential survival benefit of renal transplantation in patients with chronic kidney diseaseCMAJ.2010;182(7):666–672.
24.
RemportAKeszeiAVamosEP. Association of pretransplant dialysis duration with outcome in kidney transplant recipients: A prevalent cohort studyInt Urol Nephrol.2011; 43(1):215–224. doi: 10.1007/s11255-009-9700-4.
25.
WestJCBisordiJESquiersECLatshaRMillerJKelleySE. Length of time on dialysis prior to renal transplantation is a critical factor affecting patient survival after allograftingTranspl Int.1992;5(suppl 1):S148–150.
26.
Goldfarb-RumyantzevAHurdleJFScandlingJ. Duration of end-stage renal disease and kidney transplant outcomeNephrol Dial Transplant.2005;20(1):167–175.
27.
PotluriKHouS. Obesity in kidney transplant recipients and candidatesAm J Kidney Dis.2010;56(1):143–156.
28.
GoreJLPhamPTDanovitchGM. Obesity and outcome following renal transplantationAm J Transplant.2006;6(2):357–363.
29.
BrarAJindalRMElsterEA. Effect of peripheral vascular disease on kidney allograft outcomes: A study of U.S. Renal data systemTransplantation.2013;95(6):810–815.
30.
OjoAOHansonJAWolfeRALeichtmanABAgodoaLYPortFK. Long-term survival in renal transplant recipients with graft functionKidney Int.2000;57(1):307–313.
31.
AhmedKAhmadNKhanMS. Influence of number of retransplants on renal graft outcomeTransplant Proc.2008;40(5):1349–1352.
32.
ZelleDMCorpeleijnEStolkRP. Low physical activity and risk of cardiovascular and all-cause mortality in renal transplant recipientsClin J Am Soc Nephrol.2011;6(4):898–905.
YangoAFGohhRYMonacoAP. Excess risk of renal allograft loss and early mortality among elderly recipients is associated with poor exercise capacityClin Nephrol.2006;65(6):401–407.
35.
WuCEvansIJosephR. Comorbid conditions in kidney transplantation: Association with graft and patient survivalJ Am Soc Nephrol.2005;16(11):3437–3444.
36.
GrossoGCoronaDMistrettaA. Predictive value of the Charlson comorbidity index in kidney transplantationTransplant Proc.2012;44(7):1859–1863.
37.
Baskin-BeyESKremersWNybergSL. A recipient risk score for deceased donor renal allocationAm J Kidney Dis.2007;49(2):284–293.
38.
HariharanSMcBrideMACherikhWSTollerisCBBresnahanBAJohnsonCP. Post-transplant renal function in the first year predicts long-term kidney transplant survivalKidney Int.2002;62(1):311–318.
39.
Goldfarb-RumyantzevASScandlingJDPappasLSmoutRJHornS. Prediction of 3-yr cadaveric graft survival based on pre-transplant variables in a large national datasetClin Transplant.2003;17(6):485–497.
40.
ScholdJDKaplanBBaligaRSMeier-KriescheHU. The broad spectrum of quality in deceased donor kidneysAm J Transplant.2005;5(4 pt 1):757–765.
41.
MoersCKornmannNSLeuveninkHGPloegRJ. The influence of deceased donor age and old-for-old allocation on kidney transplant outcomeTransplantation.2009;88(4):542–452.
42.
MachnickiGPinskyBTakemotoS. Predictive ability of pretransplant comorbidities to predict long-term graft loss and deathAm J Transplant.2009;9(3):494–505.
43.
KrikovSKhanABairdBCBarenbaumLLLeviatovAKofordJKGoldfarb-RumyantzevAS. Predicting kidney transplant survival using tree-based modelingASAIO J.2007;53(5):592–600.
44.
JassalSVSchaubelDEFentonSS. Predicting mortality after kidney transplantation: A clinical toolTranspl Int.2005;18(11):1248–1257.
45.
PielochDDombrovskiyVOsbandAJLebowitzJLaskowDA. Morbid obesity is not an independent predictor of graft failure or patient mortality after kidney transplantationJ Ren Nutr.2014;24(1):50–57.
46.
LongeneckerJCCoreshJKlagMJ. Validation of comorbid conditions on the end-stage renal disease medical evidence report: The CHOICE Study. Choices for Healthy Outcomes in Caring for ESRDJ Am Soc Nephrol.2000;11(3):520–529.
